Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2011/402052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850227509528887296 |
|---|---|
| author | Hassan Kahal Stephen L. Atkin Thozhukat Sathyapalan |
| author_facet | Hassan Kahal Stephen L. Atkin Thozhukat Sathyapalan |
| author_sort | Hassan Kahal |
| collection | DOAJ |
| description | Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed. |
| format | Article |
| id | doaj-art-138633d6ba2d400ba49a79db3dfe1b28 |
| institution | OA Journals |
| issn | 2090-0708 2090-0716 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Obesity |
| spelling | doaj-art-138633d6ba2d400ba49a79db3dfe1b282025-08-20T02:04:49ZengWileyJournal of Obesity2090-07082090-07162011-01-01201110.1155/2011/402052402052Pharmacological Treatment of Obesity in Patients with Polycystic Ovary SyndromeHassan Kahal0Stephen L. Atkin1Thozhukat Sathyapalan2Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU3 2RW, UKAcademic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU3 2RW, UKAcademic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU3 2RW, UKPolycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.http://dx.doi.org/10.1155/2011/402052 |
| spellingShingle | Hassan Kahal Stephen L. Atkin Thozhukat Sathyapalan Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome Journal of Obesity |
| title | Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome |
| title_full | Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome |
| title_fullStr | Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome |
| title_full_unstemmed | Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome |
| title_short | Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome |
| title_sort | pharmacological treatment of obesity in patients with polycystic ovary syndrome |
| url | http://dx.doi.org/10.1155/2011/402052 |
| work_keys_str_mv | AT hassankahal pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome AT stephenlatkin pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome AT thozhukatsathyapalan pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome |